Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 SEP 28 ... rotigotine treatment at steady state. Twenty-four participants with idiopathic restless legs syndrome (12 per group) received levodopa/carbidopa (100 mg/25 mg bid) and rotigotine (initial ...
2009 OCT 19 ... a study from the United States, "Traditional treatment approaches for the management of restless legs syndrome (RLS) and Parkinson's disease (PD) include the use of medications that either directly ...
2009 NOV 23 ... are common in ASD, but rarely studied in ADHD. Sleep disordered breathing and restless legs syndrome have been consistently associated with ADHD. Abnormal sleep architectures, including ...
2009 NOV 23 ... and GSK. XenoPort's product candidates are being studied for the potential treatment of restless legs syndrome, gastroesophageal reflux disease, migraine headaches, neuropathic pain, spasticity ...
2009 NOV 25 ... its analysis of results from a previously suspended Phase 2 study of aplindore in Restless Legs Syndrome (RLS) and that it has entered into an agreement to sell all real estate owned by the ...
2009 NOV 23 ... "Iron deficiency has been described as a risk factor in secondary restless legs syndrome (RLS), although it has not been investigated whether iron deficiency induces sensory ...
2009 NOV 23 ... "Hemodialysis patients frequently complain of restless legs syndrome (RLS), hypoesthesia, or pruritus-all of which are attributed to a nervous system ...
2009 NOV 17 ... New research shows that Caucasian women may suffer from restless legs syndrome (RLS), a sleep disorder characterized by the strong urge to move the legs, up to four ...
2009 NOV 23 ... loci MEIS1, MAP2K5/LBXCOR1, and BTBD9, for which genome-wide association studies in restless legs syndrome and periodic limb movements during sleep revealed common risk variants. Case-control ...
2009 NOV 9 ... and such patients are likely to suffer additional sleep disruption associated with restless legs syndrome (RLS) and periodic leg movements (PLM). Our objective was to evaluate sleep quality in ...
2009 OCT 5 ... widely recognized. These include changes in sleep architecture, sleep apnea syndrome, restless legs syndrome, periodic limb movement disorder and excessive daytime sleepiness," researchers in Hong ...
2009 NOV 16 ... dopamine agonist rotigotine was developed for the treatment of Parkinson's disease and restless legs syndrome. Disposition, metabolism, elimination, and absolute bioavailability of rotigotine were ...
2009 SEP 28 ... receptor subtype-selective agonists recently approved by the FDA for the treatment of 'restless legs syndrome' (RLS). RLS is a difficult to define condition that is possibly more prevalent than ...
2009 SEP 21 ... that gabapentin improved sleep quality by addressing underlying sleep pathology, such as restless legs syndrome. "We really are not sure which mechanism is responsible, but this study ...
2009 OCT 13 ... care for more than 80 sleep disorders and other conditions, including sleep apnea, restless legs syndrome, insomnia, daytime sleepiness, and narcolepsy. "Sleep disorders can ...
2009 NOV 2 ... new drug application for XP13512 as a potential treatment for moderate-to-severe primary restless legs syndrome. XenoPort's product candidates are also being studied for the potential treatment of ...
2009 SEP 21 ... for this product candidate as a potential treatment for moderate-to-severe primary restless legs syndrome. XenoPort's product candidates are also being studied for the potential treatment of ...
